Nightingale sings
New fleet of ultrasound machines at NHS Nightingale Hospital Exeter
Read More
Author: PharmaTimes
Quantum leap
A coherent approach to rebooting drug discovery and design
Read More
Mind the gap
Proactively reducing long-term vaccine inequalities across Africa
Read More
Back to the future 3
A trio of trends that pharma needs to contend with in 2024
Read More
Craft work
Modelling the data revolution in clinical drug development
Read More- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
